Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
BerGenBio ASA
Stanford University
University of Kansas Medical Center
Roswell Park Cancer Institute
Fox Chase Cancer Center
INSYS Therapeutics Inc